BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19690545)

  • 21. CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents.
    Lombard C; Nagarkatti M; Nagarkatti P
    Clin Immunol; 2007 Mar; 122(3):259-70. PubMed ID: 17185040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CB1/CB2 receptor agonist WIN-55,212-2 reduces viability of human Kaposi's sarcoma cells in vitro.
    Luca T; Di Benedetto G; Scuderi MR; Palumbo M; Clementi S; Bernardini R; Cantarella G
    Eur J Pharmacol; 2009 Aug; 616(1-3):16-21. PubMed ID: 19539619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
    Montecucco F; Burger F; Mach F; Steffens S
    Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1145-55. PubMed ID: 18178718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase.
    Rueda D; Galve-Roperh I; Haro A; Guzmán M
    Mol Pharmacol; 2000 Oct; 58(4):814-20. PubMed ID: 10999952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor down-regulation and ceramide production.
    Mimeault M; Pommery N; Wattez N; Bailly C; Hénichart JP
    Prostate; 2003 Jun; 56(1):1-12. PubMed ID: 12746841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabinoid CB(1) receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle.
    Baldassano S; Serio R; Mule' F
    Eur J Pharmacol; 2008 Mar; 582(1-3):132-8. PubMed ID: 18234188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.
    Carracedo A; Gironella M; Lorente M; Garcia S; Guzmán M; Velasco G; Iovanna JL
    Cancer Res; 2006 Jul; 66(13):6748-55. PubMed ID: 16818650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment.
    Murikinati S; Jüttler E; Keinert T; Ridder DA; Muhammad S; Waibler Z; Ledent C; Zimmer A; Kalinke U; Schwaninger M
    FASEB J; 2010 Mar; 24(3):788-98. PubMed ID: 19884325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cannabinoid receptor 2 activation decreases severity of cyclophosphamide-induced cystitis via regulating autophagy.
    Liu Q; Wu Z; Liu Y; Chen L; Zhao H; Guo H; Zhu K; Wang W; Chen S; Zhou N; Li Y; Shi B
    Neurourol Urodyn; 2020 Jan; 39(1):158-169. PubMed ID: 31729056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-dependent activation of autophagy.
    Vara D; Salazar M; Olea-Herrero N; Guzmán M; Velasco G; Díaz-Laviada I
    Cell Death Differ; 2011 Jul; 18(7):1099-111. PubMed ID: 21475304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spisulosine (ES-285) induces prostate tumor PC-3 and LNCaP cell death by de novo synthesis of ceramide and PKCzeta activation.
    Sánchez AM; Malagarie-Cazenave S; Olea N; Vara D; Cuevas C; Díaz-Laviada I
    Eur J Pharmacol; 2008 Apr; 584(2-3):237-45. PubMed ID: 18343365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
    Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
    Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor type 1- and 2-mediated increase in cyclic AMP inhibits T cell receptor-triggered signaling.
    Börner C; Smida M; Höllt V; Schraven B; Kraus J
    J Biol Chem; 2009 Dec; 284(51):35450-60. PubMed ID: 19858202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligand activation of cannabinoid receptors attenuates hypertrophy of neonatal rat cardiomyocytes.
    Lu Y; Akinwumi BC; Shao Z; Anderson HD
    J Cardiovasc Pharmacol; 2014 Nov; 64(5):420-30. PubMed ID: 24979612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
    Ghosh S; Preet A; Groopman JE; Ganju RK
    Mol Immunol; 2006 Jul; 43(14):2169-79. PubMed ID: 16503355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ceramide is involved in r(+)-methanandamide-induced cyclooxygenase-2 expression in human neuroglioma cells.
    Ramer R; Weinzierl U; Schwind B; Brune K; Hinz B
    Mol Pharmacol; 2003 Nov; 64(5):1189-98. PubMed ID: 14573769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques.
    Montecucco F; Di Marzo V; da Silva RF; Vuilleumier N; Capettini L; Lenglet S; Pagano S; Piscitelli F; Quintao S; Bertolotto M; Pelli G; Galan K; Pilet L; Kuzmanovic K; Burger F; Pane B; Spinella G; Braunersreuther V; Gayet-Ageron A; Pende A; Viviani GL; Palombo D; Dallegri F; Roux-Lombard P; Santos RA; Stergiopulos N; Steffens S; Mach F
    Eur Heart J; 2012 Apr; 33(7):846-56. PubMed ID: 22112961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis.
    Singh UP; Singh NP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
    Toxicol Appl Pharmacol; 2012 Jan; 258(2):256-67. PubMed ID: 22119709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional relevance of the cannabinoid receptor 2 - heme oxygenase pathway: a novel target for the attenuation of portal hypertension.
    Steib CJ; Gmelin L; Pfeiler S; Schewe J; Brand S; Göke B; Gerbes AL
    Life Sci; 2013 Oct; 93(16):543-51. PubMed ID: 24007798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.